Reported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Merck & Co., Inc.
Report date November 03, 2009 · Filed November 04, 2009
Section 16 reporting ended · disclosed 2009-11-04. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common SharesSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2009-11-03 transaction · row 1
1 source rowRow 1 · 2009-11-03 · Disposition to issuer · Disposed 49,460 · Balance 0 F1: Pursuant to the agreement and plan of merger ("Merger Agreement") between the Issuer and Merck & Co., Inc. ("Merger"), upon closing of the Merger, each common share of the Issuer was converted into 0.5767 shares of Merck & Co., Inc. common stock and $10.50 in cash. |
| Common SharesSEC Table I · non-derivative | IndirectBy 401(k) | 0 |
Reported balance
After 2009-11-03 transaction · row 2
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 2 · 2009-11-03 · Disposition to issuer · Disposed 646.71 · Balance 0 F2: In connection with the Merger, each share held in the Issuer's stock fund of the Issuer's 401(k) plan was converted into 0.5767 shares of Merck & Co., Inc. common stock and $10.50 in cash. Both the shares and cash will remain in the plan until such time as the reporting person elects a distribution therefrom. |
| Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $19.23 · Expires 2013-05-18 | Direct | 0 |
Reported balance
After 2009-11-03 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2009-11-03 · Disposition to issuer · Disposed 180,000 · Balance 0 F4: Pursuant to the Merger Agreement, upon closing of the Merger, the option was converted into an option to purchase common shares of Merck & Co., Inc. in accordance with the exchange ratio set forth in the Merger Agreement. F3: The options vested and became exercisable on varying dates pursuant to the terms of the plans under which they were granted. Options that had not vested prior to the Merger, vested upon the closing of the Merger or the reporting person's termination of employment thereafter. |
| Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $16.62 · Expires 2013-07-31 | Direct | 0 |
Reported balance
After 2009-11-03 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2009-11-03 · Disposition to issuer · Disposed 30,000 · Balance 0 F4: Pursuant to the Merger Agreement, upon closing of the Merger, the option was converted into an option to purchase common shares of Merck & Co., Inc. in accordance with the exchange ratio set forth in the Merger Agreement. F3: The options vested and became exercisable on varying dates pursuant to the terms of the plans under which they were granted. Options that had not vested prior to the Merger, vested upon the closing of the Merger or the reporting person's termination of employment thereafter. |
| Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $31.57 · Expires 2014-04-30 | Direct | 0 |
Reported balance
After 2009-11-03 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2009-11-03 · Disposition to issuer · Disposed 150,000 · Balance 0 F4: Pursuant to the Merger Agreement, upon closing of the Merger, the option was converted into an option to purchase common shares of Merck & Co., Inc. in accordance with the exchange ratio set forth in the Merger Agreement. F3: The options vested and became exercisable on varying dates pursuant to the terms of the plans under which they were granted. Options that had not vested prior to the Merger, vested upon the closing of the Merger or the reporting person's termination of employment thereafter. |
| Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $20.70 · Expires 2015-04-24 | Direct | 0 |
Reported balance
After 2009-11-03 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2009-11-03 · Disposition to issuer · Disposed 179,362 · Balance 0 F4: Pursuant to the Merger Agreement, upon closing of the Merger, the option was converted into an option to purchase common shares of Merck & Co., Inc. in accordance with the exchange ratio set forth in the Merger Agreement. F3: The options vested and became exercisable on varying dates pursuant to the terms of the plans under which they were granted. Options that had not vested prior to the Merger, vested upon the closing of the Merger or the reporting person's termination of employment thereafter. |
| Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $18.85 · Expires 2015-04-30 | Direct | 0 |
Reported balance
After 2009-11-03 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2009-11-03 · Disposition to issuer · Disposed 110,000 · Balance 0 F4: Pursuant to the Merger Agreement, upon closing of the Merger, the option was converted into an option to purchase common shares of Merck & Co., Inc. in accordance with the exchange ratio set forth in the Merger Agreement. F3: The options vested and became exercisable on varying dates pursuant to the terms of the plans under which they were granted. Options that had not vested prior to the Merger, vested upon the closing of the Merger or the reporting person's termination of employment thereafter. |
| Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $22.91 · Expires 2016-04-30 | Direct | 0 |
Reported balance
After 2009-11-03 transaction · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · 2009-11-03 · Disposition to issuer · Disposed 116,500 · Balance 0 F4: Pursuant to the Merger Agreement, upon closing of the Merger, the option was converted into an option to purchase common shares of Merck & Co., Inc. in accordance with the exchange ratio set forth in the Merger Agreement. F3: The options vested and became exercisable on varying dates pursuant to the terms of the plans under which they were granted. Options that had not vested prior to the Merger, vested upon the closing of the Merger or the reporting person's termination of employment thereafter. |
| Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $18.20 · Expires 2014-02-22 | Direct | 0 |
Reported balance
After 2009-11-03 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2009-11-03 · Disposition to issuer · Disposed 74,173 · Balance 0 F4: Pursuant to the Merger Agreement, upon closing of the Merger, the option was converted into an option to purchase common shares of Merck & Co., Inc. in accordance with the exchange ratio set forth in the Merger Agreement. F3: The options vested and became exercisable on varying dates pursuant to the terms of the plans under which they were granted. Options that had not vested prior to the Merger, vested upon the closing of the Merger or the reporting person's termination of employment thereafter. |
| Phantom Stock UnitSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2009-11-03 transaction · row 10
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 10 · 2009-11-03 · Disposition to issuer · Disposed 67,062.69 · Balance 0 F5: Each unit of phantom stock is the economic equivalent of one share of common stock. F6: In connection with the Merger, each unit of phantom stock was converted into 0.5767 phantom shares of Merck & Co., Inc. common stock and $10.50 in cash. The cash value of the phantom stock units will be paid to the reporting person in accordance with the reporting person's distribution election under the Issuer's nonqualified deferred compensation plan. |
Filing footnotes · ownership attribution and instrument terms
F1: Pursuant to the agreement and plan of merger ("Merger Agreement") between the Issuer and Merck & Co., Inc. ("Merger"), upon closing of the Merger, each common share of the Issuer was converted into 0.5767 shares of Merck & Co., Inc. common stock and $10.50 in cash.
F2: In connection with the Merger, each share held in the Issuer's stock fund of the Issuer's 401(k) plan was converted into 0.5767 shares of Merck & Co., Inc. common stock and $10.50 in cash. Both the shares and cash will remain in the plan until such time as the reporting person elects a distribution therefrom.
F3: The options vested and became exercisable on varying dates pursuant to the terms of the plans under which they were granted. Options that had not vested prior to the Merger, vested upon the closing of the Merger or the reporting person's termination of employment thereafter.
F4: Pursuant to the Merger Agreement, upon closing of the Merger, the option was converted into an option to purchase common shares of Merck & Co., Inc. in accordance with the exchange ratio set forth in the Merger Agreement.
F5: Each unit of phantom stock is the economic equivalent of one share of common stock.
F6: In connection with the Merger, each unit of phantom stock was converted into 0.5767 phantom shares of Merck & Co., Inc. common stock and $10.50 in cash. The cash value of the phantom stock units will be paid to the reporting person in accordance with the reporting person's distribution election under the Issuer's nonqualified deferred compensation plan.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 03, 2009 Filed Nov 4, 2009 22:51 UTC | Merck & Co., Inc. SGP · Entity 2807 | Disposition to issuerPhantom Stock Unit · Derivative | 67,062.69 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-09-051067 · c91908_4x1.xml · derivative · entry 10 CHEELEY C RON · CIK 0001256917 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 67,062.69 shares Expires not disclosed F5 · derivative.exercise_price: Each unit of phantom stock is the economic equivalent of one share of common stock. F6 · price: In connection with the Merger, each unit of phantom stock was converted into 0.5767 phantom shares of Merck & Co., Inc. common stock and $10.50 in cash. The cash value of the phantom stock units will be paid to the reporting person in accordance with the reporting person's distribution election under the Issuer's nonqualified deferred compensation plan. F6 · derivative.exercise_date: In connection with the Merger, each unit of phantom stock was converted into 0.5767 phantom shares of Merck & Co., Inc. common stock and $10.50 in cash. The cash value of the phantom stock units will be paid to the reporting person in accordance with the reporting person's distribution election under the Issuer's nonqualified deferred compensation plan. F6 · derivative.expiration_date: In connection with the Merger, each unit of phantom stock was converted into 0.5767 phantom shares of Merck & Co., Inc. common stock and $10.50 in cash. The cash value of the phantom stock units will be paid to the reporting person in accordance with the reporting person's distribution election under the Issuer's nonqualified deferred compensation plan. Read SEC document |
| November 03, 2009 Filed Nov 4, 2009 22:51 UTC | Merck & Co., Inc. SGP · Entity 2807 | Disposition to issuerOption (right to buy) · Derivative | 116,500 | Not disclosed Strike: $22.91 | Not disclosed |
DisclosureSEC source: 0001209191-09-051067 · c91908_4x1.xml · derivative · entry 9 CHEELEY C RON · CIK 0001256917 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 116,500 shares Expires 2016-04-30 F4 · price: Pursuant to the Merger Agreement, upon closing of the Merger, the option was converted into an option to purchase common shares of Merck & Co., Inc. in accordance with the exchange ratio set forth in the Merger Agreement. F3 · derivative.exercise_date: The options vested and became exercisable on varying dates pursuant to the terms of the plans under which they were granted. Options that had not vested prior to the Merger, vested upon the closing of the Merger or the reporting person's termination of employment thereafter. Read SEC document |
| November 03, 2009 Filed Nov 4, 2009 22:51 UTC | Merck & Co., Inc. SGP · Entity 2807 | Disposition to issuerOption (right to buy) · Derivative | 110,000 | Not disclosed Strike: $18.85 | Not disclosed |
DisclosureSEC source: 0001209191-09-051067 · c91908_4x1.xml · derivative · entry 8 CHEELEY C RON · CIK 0001256917 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 110,000 shares Expires 2015-04-30 F4 · price: Pursuant to the Merger Agreement, upon closing of the Merger, the option was converted into an option to purchase common shares of Merck & Co., Inc. in accordance with the exchange ratio set forth in the Merger Agreement. F3 · derivative.exercise_date: The options vested and became exercisable on varying dates pursuant to the terms of the plans under which they were granted. Options that had not vested prior to the Merger, vested upon the closing of the Merger or the reporting person's termination of employment thereafter. Read SEC document |
| November 03, 2009 Filed Nov 4, 2009 22:51 UTC | Merck & Co., Inc. SGP · Entity 2807 | Disposition to issuerOption (right to buy) · Derivative | 179,362 | Not disclosed Strike: $20.70 | Not disclosed |
DisclosureSEC source: 0001209191-09-051067 · c91908_4x1.xml · derivative · entry 7 CHEELEY C RON · CIK 0001256917 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 179,362 shares Expires 2015-04-24 F4 · price: Pursuant to the Merger Agreement, upon closing of the Merger, the option was converted into an option to purchase common shares of Merck & Co., Inc. in accordance with the exchange ratio set forth in the Merger Agreement. F3 · derivative.exercise_date: The options vested and became exercisable on varying dates pursuant to the terms of the plans under which they were granted. Options that had not vested prior to the Merger, vested upon the closing of the Merger or the reporting person's termination of employment thereafter. Read SEC document |
| November 03, 2009 Filed Nov 4, 2009 22:51 UTC | Merck & Co., Inc. SGP · Entity 2807 | Disposition to issuerOption (right to buy) · Derivative | 150,000 | Not disclosed Strike: $31.57 | Not disclosed |
DisclosureSEC source: 0001209191-09-051067 · c91908_4x1.xml · derivative · entry 6 CHEELEY C RON · CIK 0001256917 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 150,000 shares Expires 2014-04-30 F4 · price: Pursuant to the Merger Agreement, upon closing of the Merger, the option was converted into an option to purchase common shares of Merck & Co., Inc. in accordance with the exchange ratio set forth in the Merger Agreement. F3 · derivative.exercise_date: The options vested and became exercisable on varying dates pursuant to the terms of the plans under which they were granted. Options that had not vested prior to the Merger, vested upon the closing of the Merger or the reporting person's termination of employment thereafter. Read SEC document |
| November 03, 2009 Filed Nov 4, 2009 22:51 UTC | Merck & Co., Inc. SGP · Entity 2807 | Disposition to issuerOption (Right to Buy) · Derivative | 74,173 | Not disclosed Strike: $18.20 | Not disclosed |
DisclosureSEC source: 0001209191-09-051067 · c91908_4x1.xml · derivative · entry 5 CHEELEY C RON · CIK 0001256917 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 74,173 shares Expires 2014-02-22 F4 · price: Pursuant to the Merger Agreement, upon closing of the Merger, the option was converted into an option to purchase common shares of Merck & Co., Inc. in accordance with the exchange ratio set forth in the Merger Agreement. F3 · derivative.exercise_date: The options vested and became exercisable on varying dates pursuant to the terms of the plans under which they were granted. Options that had not vested prior to the Merger, vested upon the closing of the Merger or the reporting person's termination of employment thereafter. Read SEC document |
| November 03, 2009 Filed Nov 4, 2009 22:51 UTC | Merck & Co., Inc. SGP · Entity 2807 | Disposition to issuerOption (right to buy) · Derivative | 30,000 | Not disclosed Strike: $16.62 | Not disclosed |
DisclosureSEC source: 0001209191-09-051067 · c91908_4x1.xml · derivative · entry 4 CHEELEY C RON · CIK 0001256917 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 30,000 shares Expires 2013-07-31 F4 · price: Pursuant to the Merger Agreement, upon closing of the Merger, the option was converted into an option to purchase common shares of Merck & Co., Inc. in accordance with the exchange ratio set forth in the Merger Agreement. F3 · derivative.exercise_date: The options vested and became exercisable on varying dates pursuant to the terms of the plans under which they were granted. Options that had not vested prior to the Merger, vested upon the closing of the Merger or the reporting person's termination of employment thereafter. Read SEC document |
| November 03, 2009 Filed Nov 4, 2009 22:51 UTC | Merck & Co., Inc. SGP · Entity 2807 | Disposition to issuerOption (right to buy) · Derivative | 180,000 | Not disclosed Strike: $19.23 | Not disclosed |
DisclosureSEC source: 0001209191-09-051067 · c91908_4x1.xml · derivative · entry 3 CHEELEY C RON · CIK 0001256917 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 180,000 shares Expires 2013-05-18 F4 · price: Pursuant to the Merger Agreement, upon closing of the Merger, the option was converted into an option to purchase common shares of Merck & Co., Inc. in accordance with the exchange ratio set forth in the Merger Agreement. F3 · derivative.exercise_date: The options vested and became exercisable on varying dates pursuant to the terms of the plans under which they were granted. Options that had not vested prior to the Merger, vested upon the closing of the Merger or the reporting person's termination of employment thereafter. Read SEC document |
| November 03, 2009 Filed Nov 4, 2009 22:51 UTC | Merck & Co., Inc. SGP · Entity 2807 | Disposition to issuerCommon Shares | 646.71 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-09-051067 · c91908_4x1.xml · nonDerivative · entry 2 CHEELEY C RON · CIK 0001256917 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Indirect · By 401(k) Disclosed balance after: 0 F2 · price: In connection with the Merger, each share held in the Issuer's stock fund of the Issuer's 401(k) plan was converted into 0.5767 shares of Merck & Co., Inc. common stock and $10.50 in cash. Both the shares and cash will remain in the plan until such time as the reporting person elects a distribution therefrom. Read SEC document |
| November 03, 2009 Filed Nov 4, 2009 22:51 UTC | Merck & Co., Inc. SGP · Entity 2807 | Disposition to issuerCommon Shares | 49,460 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-09-051067 · c91908_4x1.xml · nonDerivative · entry 1 CHEELEY C RON · CIK 0001256917 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · price: Pursuant to the agreement and plan of merger ("Merger Agreement") between the Issuer and Merck & Co., Inc. ("Merger"), upon closing of the Merger, each common share of the Issuer was converted into 0.5767 shares of Merck & Co., Inc. common stock and $10.50 in cash. Read SEC document |
| May 01, 2009 Filed May 5, 2009 17:56 UTC | Merck & Co., Inc. SGP · Entity 2807 | GrantOption (right to buy) · Derivative | 116,500 | Not disclosed Strike: $22.91 | Not disclosed |
DisclosureSEC source: 0000310158-09-000047 · che725.xml · derivative · entry 1 CHEELEY C RON · CIK 0001256917 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 116,500 Underlying: Common Shares · 116,500 shares Expires 2016-04-30 F2 · price: Not Applicable. F1 · derivative.exercise_date: Granted under the Schering-Plough Corporation 2006 Stock Incentive Plan and exercisable in one-third increments on May 1 of 2010, 2011 and 2012. The vesting of 23,300 option shares is subject to Schering-Plough's satisfaction of certain performance criteria for the 2009 year. Read SEC document |
| April 01, 2009 Filed Apr 3, 2009 19:05 UTC | Merck & Co., Inc. SGP · Entity 2807 | Exercise / conversionDeferred Stock Unit Award · Derivative | 25,000 | Not disclosed Strike: $0.00 | Not disclosed |
DisclosureSEC source: 0000310158-09-000031 · che715.xml · derivative · entry 4 CHEELEY C RON · CIK 0001256917 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 25,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Not Applicable. F6 · price: Not Applicable. F4 · derivative.exercise_date: Not Applicable. F5 · derivative.expiration_date: Not Applicable. Read SEC document |
| April 01, 2009 Filed Apr 3, 2009 19:05 UTC | Merck & Co., Inc. SGP · Entity 2807 | Tax withholdingCommon Shares | 11,588 | $23.70 | $274,635.60 |
DisclosureSEC source: 0000310158-09-000031 · che715.xml · nonDerivative · entry 2 CHEELEY C RON · CIK 0001256917 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,460 Read SEC document |
| April 01, 2009 Filed Apr 3, 2009 19:05 UTC | Merck & Co., Inc. SGP · Entity 2807 | Exercise / conversionCommon Shares | 25,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000310158-09-000031 · che715.xml · nonDerivative · entry 1 CHEELEY C RON · CIK 0001256917 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,048 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Not Applicable. Read SEC document |
| February 27, 2009 Filed Mar 3, 2009 22:09 UTC | Merck & Co., Inc. SGP · Entity 2807 | GrantPhantom Stock Unit · Derivative | 65,203 | $17.39 | $1,133,880.17 |
DisclosureSEC source: 0000310158-09-000008 · che706.xml · derivative · entry 1 CHEELEY C RON · CIK 0001256917 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,671.8 Underlying: Common Shares · 65,203 shares Expires not disclosed F1 · derivative.exercise_price: Each unit of phantom stock is the economic equivalent of one share of common stock. The units of phantom stock will be held in the Issuer's Phantom Stock Fund under the Issuer's non-qualified deferred compensation plan, and will become payable, in cash, following the reporting person's termination of service. F1 · derivative.exercise_date: Each unit of phantom stock is the economic equivalent of one share of common stock. The units of phantom stock will be held in the Issuer's Phantom Stock Fund under the Issuer's non-qualified deferred compensation plan, and will become payable, in cash, following the reporting person's termination of service. F1 · derivative.expiration_date: Each unit of phantom stock is the economic equivalent of one share of common stock. The units of phantom stock will be held in the Issuer's Phantom Stock Fund under the Issuer's non-qualified deferred compensation plan, and will become payable, in cash, following the reporting person's termination of service. F2 · balance_after: These units include 81.99 deemed units of interest in the Issuer's phantom stock fund under the Issuer's non-qualified deferred compensation plan, as of February 27, 2009. The number of shares underlying each unit may fluctuate based on deemed plan holdings. Read SEC document |
| May 14, 2008 Filed May 14, 2008 19:54 UTC | Merck & Co., Inc. SGP · Entity 2807 | OtherCommon Shares | 1,180 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000310158-08-000046 · che669.xml · nonDerivative · entry 1 CHEELEY C RON · CIK 0001256917 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,048 F1 · price: Not Applicable. F2 · balance_after: The reporting person transferred the shares of Schering-Plough Corporation common stock to his ex-wife pursuant to an agreement in connection with a divorce. Read SEC document |
| May 01, 2008 Filed May 5, 2008 20:36 UTC | Merck & Co., Inc. SGP · Entity 2807 | GrantOption (right to buy) · Derivative | 110,000 | Not disclosed Strike: $18.85 | Not disclosed |
DisclosureSEC source: 0000310158-08-000028 · che660.xml · derivative · entry 1 CHEELEY C RON · CIK 0001256917 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,000 Underlying: Common Shares · 110,000 shares Expires 2015-04-30 F2 · price: Not Applicable. F1 · derivative.exercise_date: Granted under the Schering-Plough Corporation 2006 Stock Incentive Plan and exercisable in one-third increments on May 1 of 2009, 2010 and 2011. The vesting of 22,000 option shares is subject to Schering-Plough's satisfaction of certain performance criteria for the 2008 year. Read SEC document |
| April 25, 2008 Filed Apr 29, 2008 19:41 UTC | Merck & Co., Inc. SGP · Entity 2807 | Exercise / conversionDeferred Stock Unit Award · Derivative | 30,000 | Not disclosed Strike: $0.00 | Not disclosed |
DisclosureSEC source: 0000310158-08-000012 · che650.xml · derivative · entry 4 CHEELEY C RON · CIK 0001256917 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Shares · 30,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Not Applicable. F6 · price: Not Applicable. F4 · derivative.exercise_date: Not Applicable. F5 · derivative.expiration_date: Not Applicable. Read SEC document |
| April 25, 2008 Filed Apr 29, 2008 19:41 UTC | Merck & Co., Inc. SGP · Entity 2807 | Tax withholdingCommon Shares | 11,130 | $18.64 | $207,463.20 |
DisclosureSEC source: 0000310158-08-000012 · che650.xml · nonDerivative · entry 2 CHEELEY C RON · CIK 0001256917 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,228 Read SEC document |
| April 25, 2008 Filed Apr 29, 2008 19:41 UTC | Merck & Co., Inc. SGP · Entity 2807 | Exercise / conversionCommon Shares | 30,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000310158-08-000012 · che650.xml · nonDerivative · entry 1 CHEELEY C RON · CIK 0001256917 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,358 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Not Applicable. Read SEC document |
| May 21, 2007 Filed May 22, 2007 18:41 UTC | Merck & Co., Inc. SGP · Entity 2807 | Exercise / conversionOption (Right to Buy) · Derivative | 50,720 | Not disclosed Strike: $18.20 | Not disclosed |
DisclosureSEC source: 0000310158-07-000038 · che614.xml · derivative · entry 7 CHEELEY C RON · CIK 0001256917 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,173 Underlying: Common Shares · 50,720 shares Expires 2014-02-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · price: Not Applicable. F4 · derivative.exercise_date: Granted under the Schering-Plough Corporation 2002 Stock Incentive Plan. This stock option vested and became exercisable in one-third increments on February 24 of 2005, 2006 and 2007. Read SEC document |
| May 21, 2007 Filed May 22, 2007 18:41 UTC | Merck & Co., Inc. SGP · Entity 2807 | Exercise / conversionOption (right to buy) · Derivative | 49,280 | Not disclosed Strike: $16.62 | Not disclosed |
DisclosureSEC source: 0000310158-07-000038 · che614.xml · derivative · entry 6 CHEELEY C RON · CIK 0001256917 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Shares · 49,280 shares Expires 2013-07-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · price: Not Applicable. F2 · derivative.exercise_date: Granted under the Schering-Plough Corporation 2002 Stock Incentive Plan. This stock option vested and became exercisable in one-third increments on August 2 of 2004, 2005 and 2006. Read SEC document |
| May 21, 2007 Filed May 22, 2007 18:41 UTC | Merck & Co., Inc. SGP · Entity 2807 | Tax withholdingCommon Shares | 21,986 | $33.14 | $728,616.04 |
DisclosureSEC source: 0000310158-07-000038 · che614.xml · nonDerivative · entry 4 CHEELEY C RON · CIK 0001256917 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,358 Read SEC document |
| May 21, 2007 Filed May 22, 2007 18:41 UTC | Merck & Co., Inc. SGP · Entity 2807 | SaleCommon Shares | 78,014 | $33.40 | $2,605,667.60 |
DisclosureSEC source: 0000310158-07-000038 · che614.xml · nonDerivative · entry 3 CHEELEY C RON · CIK 0001256917 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,344 Read SEC document |
| May 21, 2007 Filed May 22, 2007 18:41 UTC | Merck & Co., Inc. SGP · Entity 2807 | Exercise / conversionCommon Shares | 50,720 | $18.20 | $923,104.00 |
DisclosureSEC source: 0000310158-07-000038 · che614.xml · nonDerivative · entry 2 CHEELEY C RON · CIK 0001256917 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 118,358 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 21, 2007 Filed May 22, 2007 18:41 UTC | Merck & Co., Inc. SGP · Entity 2807 | Exercise / conversionCommon Shares | 49,280 | $16.62 | $819,033.60 |
DisclosureSEC source: 0000310158-07-000038 · che614.xml · nonDerivative · entry 1 CHEELEY C RON · CIK 0001256917 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,638 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 01, 2007 Filed May 3, 2007 14:12 UTC | Merck & Co., Inc. SGP · Entity 2807 | Exercise / conversionOption (right to buy) · Derivative | 6,886 | Not disclosed Strike: $20.70 | Not disclosed |
DisclosureSEC source: 0000310158-07-000025 · che601.xml · derivative · entry 10 CHEELEY C RON · CIK 0001256917 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 179,362 Underlying: Common Shares · 6,886 shares Expires 2015-04-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · price: Not Applicable. F5 · derivative.exercise_date: Granted under the Schering-Plough Corporation 2002 Stock Incentive Plan, exercisable in one-third increments on April 26 of 2006, 2007 and 2008. Read SEC document |
| May 01, 2007 Filed May 3, 2007 14:12 UTC | Merck & Co., Inc. SGP · Entity 2807 | GrantOption (right to buy) · Derivative | 150,000 | Not disclosed Strike: $31.57 | Not disclosed |
DisclosureSEC source: 0000310158-07-000025 · che601.xml · derivative · entry 9 CHEELEY C RON · CIK 0001256917 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,000 Underlying: Common Shares · 150,000 shares Expires 2014-04-30 F3 · price: Not Applicable. F4 · derivative.exercise_date: Granted under the Schering-Plough Corporation 2006 Stock Incentive Plan and exercisable in one-third increments on May 1 of 2008, 2009 and 2010. The vesting of 30,000 option shares is subject to Schering-Plough's satisfaction of certain performance criteria for the 2007 year. Read SEC document |
| May 01, 2007 Filed May 3, 2007 14:12 UTC | Merck & Co., Inc. SGP · Entity 2807 | Exercise / conversionOption (Right to Buy) · Derivative | 14,051 | Not disclosed Strike: $18.20 | Not disclosed |
DisclosureSEC source: 0000310158-07-000025 · che601.xml · derivative · entry 8 CHEELEY C RON · CIK 0001256917 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 124,893 Underlying: Common Shares · 14,051 shares Expires 2014-02-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · price: Not Applicable. F2 · derivative.exercise_date: Granted under the Schering-Plough Corporation 2002 Stock Incentive Plan. This stock option vested and became exercisable in one-third increments on February 24 of 2005, 2006 and 2007. Read SEC document |
| May 01, 2007 Filed May 3, 2007 14:12 UTC | Merck & Co., Inc. SGP · Entity 2807 | Tax withholdingCommon Shares | 3,424 | $31.73 | $108,643.52 |
DisclosureSEC source: 0000310158-07-000025 · che601.xml · nonDerivative · entry 6 CHEELEY C RON · CIK 0001256917 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,358 Read SEC document |
| May 01, 2007 Filed May 3, 2007 14:12 UTC | Merck & Co., Inc. SGP · Entity 2807 | SaleCommon Shares | 8,413 | $31.51 | $265,093.63 |
DisclosureSEC source: 0000310158-07-000025 · che601.xml · nonDerivative · entry 5 CHEELEY C RON · CIK 0001256917 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,782 Read SEC document |
| May 01, 2007 Filed May 3, 2007 14:12 UTC | Merck & Co., Inc. SGP · Entity 2807 | SaleCommon Shares | 4,300 | $31.50 | $135,450.00 |
DisclosureSEC source: 0000310158-07-000025 · che601.xml · nonDerivative · entry 4 CHEELEY C RON · CIK 0001256917 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,195 Read SEC document |
| May 01, 2007 Filed May 3, 2007 14:12 UTC | Merck & Co., Inc. SGP · Entity 2807 | SaleCommon Shares | 4,800 | $31.49 | $151,152.00 |
DisclosureSEC source: 0000310158-07-000025 · che601.xml · nonDerivative · entry 3 CHEELEY C RON · CIK 0001256917 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,495 Read SEC document |
| May 01, 2007 Filed May 3, 2007 14:12 UTC | Merck & Co., Inc. SGP · Entity 2807 | Exercise / conversionCommon Shares | 6,886 | $20.70 | $142,540.20 |
DisclosureSEC source: 0000310158-07-000025 · che601.xml · nonDerivative · entry 2 CHEELEY C RON · CIK 0001256917 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,295 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 01, 2007 Filed May 3, 2007 14:12 UTC | Merck & Co., Inc. SGP · Entity 2807 | Exercise / conversionCommon Shares | 14,051 | $18.20 | $255,728.20 |
DisclosureSEC source: 0000310158-07-000025 · che601.xml · nonDerivative · entry 1 CHEELEY C RON · CIK 0001256917 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,409 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 31, 2007 Filed Feb 1, 2007 19:52 UTC | Merck & Co., Inc. SGP · Entity 2807 | Exercise / conversionOption (right to buy) · Derivative | 13,752 | Not disclosed Strike: $20.70 | Not disclosed |
DisclosureSEC source: 0000310158-07-000002 · che595.xml · derivative · entry 9 CHEELEY C RON · CIK 0001256917 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 186,248 Underlying: Common Shares · 13,752 shares Expires 2015-04-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · price: Not Applicable. F5 · derivative.exercise_date: Granted under the Schering-Plough Corporation 2002 Stock Incentive Plan, exercisable in one-third increments on April 26 of each 2006, 2007 and 2008, subject to Schering-Plough's satisfaction of certain performance criteria for the year 2005 with respect to 40,000 option shares. Read SEC document |
| January 31, 2007 Filed Feb 1, 2007 19:52 UTC | Merck & Co., Inc. SGP · Entity 2807 | Exercise / conversionOption (Right to Buy) · Derivative | 21,056 | Not disclosed Strike: $18.20 | Not disclosed |
DisclosureSEC source: 0000310158-07-000002 · che595.xml · derivative · entry 8 CHEELEY C RON · CIK 0001256917 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 138,944 Underlying: Common Shares · 21,056 shares Expires 2014-02-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · price: Not Applicable. F4 · derivative.exercise_date: Granted under the Schering-Plough Corporation 2002 Stock Incentive Plan, exercisable in one-third increments on February 24 of each 2005, 2006 and 2007. Read SEC document |
| January 31, 2007 Filed Feb 1, 2007 19:52 UTC | Merck & Co., Inc. SGP · Entity 2807 | Exercise / conversionOption (right to buy) · Derivative | 10,720 | Not disclosed Strike: $16.62 | Not disclosed |
DisclosureSEC source: 0000310158-07-000002 · che595.xml · derivative · entry 7 CHEELEY C RON · CIK 0001256917 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,280 Underlying: Common Shares · 10,720 shares Expires 2013-07-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · price: Not Applicable. F2 · derivative.exercise_date: Granted under the Schering-Plough Corporation 2002 Stock Incentive Plan, exercisable in one-third increments on August 2 of each 2004, 2005 and 2006. Read SEC document |
| January 31, 2007 Filed Feb 1, 2007 19:52 UTC | Merck & Co., Inc. SGP · Entity 2807 | SaleCommon Shares | 41,480 | $24.88 | $1,032,022.40 |
DisclosureSEC source: 0000310158-07-000002 · che595.xml · nonDerivative · entry 5 CHEELEY C RON · CIK 0001256917 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,358 Read SEC document |
| January 31, 2007 Filed Feb 1, 2007 19:52 UTC | Merck & Co., Inc. SGP · Entity 2807 | Tax withholdingCommon Shares | 4,048 | $24.88 | $100,714.24 |
DisclosureSEC source: 0000310158-07-000002 · che595.xml · nonDerivative · entry 4 CHEELEY C RON · CIK 0001256917 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,838 Read SEC document |
| January 31, 2007 Filed Feb 1, 2007 19:52 UTC | Merck & Co., Inc. SGP · Entity 2807 | Exercise / conversionCommon Shares | 13,752 | $20.70 | $284,666.40 |
DisclosureSEC source: 0000310158-07-000002 · che595.xml · nonDerivative · entry 3 CHEELEY C RON · CIK 0001256917 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,886 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 31, 2007 Filed Feb 1, 2007 19:52 UTC | Merck & Co., Inc. SGP · Entity 2807 | Exercise / conversionCommon Shares | 21,056 | $18.20 | $383,219.20 |
DisclosureSEC source: 0000310158-07-000002 · che595.xml · nonDerivative · entry 2 CHEELEY C RON · CIK 0001256917 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,134 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 31, 2007 Filed Feb 1, 2007 19:52 UTC | Merck & Co., Inc. SGP · Entity 2807 | Exercise / conversionCommon Shares | 10,720 | $16.62 | $178,166.40 |
DisclosureSEC source: 0000310158-07-000002 · che595.xml · nonDerivative · entry 1 CHEELEY C RON · CIK 0001256917 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,078 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 30, 2007 Filed Feb 1, 2007 19:52 UTC | Merck & Co., Inc. SGP · Entity 2807 | OtherPhantom Stock Unit · Derivative | 97.6 | $24.96 | $2,436.10 |
DisclosureSEC source: 0000310158-07-000002 · che595.xml · derivative · entry 10 CHEELEY C RON · CIK 0001256917 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,433.23 Underlying: Common Shares · 97.6 shares Expires not disclosed F6 · derivative.exercise_price: 1 for 1 F7 · derivative.exercise_date: Shares of phantom stock are payable in cash following the reporting person's termination of employment with the Issuer and may be transferred by the reporting person into an alternative investment account at any time. F7 · derivative.expiration_date: Shares of phantom stock are payable in cash following the reporting person's termination of employment with the Issuer and may be transferred by the reporting person into an alternative investment account at any time. F8 · balance_after: These shares underlie 79.88 deemed units of interest in the Issuer's phantom stock fund under the Issuer's non-qualified deferred compensation plan, as of January 30, 2007. The number of shares underlying each unit may fluctuate based on deemed plan holdings. Read SEC document |
| December 13, 2006 Filed Dec 13, 2006 17:34 UTC | Merck & Co., Inc. SGP · Entity 2807 | OtherCommon Shares | 3,805 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000310158-06-000153 · che594.xml · nonDerivative · entry 1 CHEELEY C RON · CIK 0001256917 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,358 F1 · price: Not Applicable. F2 · balance_after: The reporting person transferred the shares of Schering-Plough Corporation common stock to his ex-wife pursuant to an agreement in connection with a divorce. Read SEC document |
| December 01, 2006 Filed Dec 5, 2006 01:25 UTC | Merck & Co., Inc. SGP · Entity 2807 | Exercise / conversionDeferred Stock Unit Award · Derivative | 25,000 | Not disclosed Strike: $0.00 | Not disclosed |
DisclosureSEC source: 0000310158-06-000144 · che579.xml · derivative · entry 4 CHEELEY C RON · CIK 0001256917 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,000 Underlying: Common Shares · 25,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Not Applicable. F6 · price: Not Applicable. F4 · derivative.exercise_date: Not Applicable. F5 · derivative.expiration_date: Not Applicable. Read SEC document |
| December 01, 2006 Filed Dec 5, 2006 01:25 UTC | Merck & Co., Inc. SGP · Entity 2807 | Tax withholdingCommon Shares | 11,588 | $21.93 | $254,124.84 |
DisclosureSEC source: 0000310158-06-000144 · che579.xml · nonDerivative · entry 2 CHEELEY C RON · CIK 0001256917 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,163 Read SEC document |
| December 01, 2006 Filed Dec 5, 2006 01:25 UTC | Merck & Co., Inc. SGP · Entity 2807 | Exercise / conversionCommon Shares | 25,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000310158-06-000144 · che579.xml · nonDerivative · entry 1 CHEELEY C RON · CIK 0001256917 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,751 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Not Applicable. Read SEC document |
| November 07, 2006 Filed Nov 9, 2006 15:48 UTC | Merck & Co., Inc. SGP · Entity 2807 | OtherCommon Shares | 5,161 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000310158-06-000111 · che569.xml · nonDerivative · entry 1 CHEELEY C RON · CIK 0001256917 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,751 F1 · price: Not Applicable. F2 · balance_after: The reporting person transferred the shares of Schering-Plough Corporation common stock to his ex-wife pursuant to an agreement in connection with a divorce. Read SEC document |
| October 23, 2006 Filed Oct 25, 2006 19:36 UTC | Merck & Co., Inc. SGP · Entity 2807 | OtherPhantom Stock Unit · Derivative | 252.41 | $22.83 | $5,762.52 |
DisclosureSEC source: 0000310158-06-000106 · che567.xml · derivative · entry 1 CHEELEY C RON · CIK 0001256917 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,335.63 Underlying: Common Shares · 252.41 shares Expires not disclosed F1 · derivative.exercise_price: 1 for 1 F2 · derivative.exercise_date: Shares of phantom stock are payable in cash following the reporting person's termination of employment with the Issuer and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: Shares of phantom stock are payable in cash following the reporting person's termination of employment with the Issuer and may be transferred by the reporting person into an alternative investment account at any time. F3 · balance_after: These shares underlie 74.36 deemed units of interest in the Issuer's phantom stock fund under the Issuer's non-qualified deferred compensation plan, as of October 23, 2006. The number of shares underlying each unit may fluctuate based on deemed plan holdings. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.